Jennifer Dearborn-Tomazos, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ischemic Attack, Transient | 5 | 2021 | 899 | 1.680 |
Why?
|
| Stroke | 15 | 2024 | 9952 | 1.180 |
Why?
|
| Adiponectin | 3 | 2015 | 1114 | 0.730 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2020 | 137 | 0.680 |
Why?
|
| Nutritive Value | 2 | 2019 | 349 | 0.660 |
Why?
|
| Independent Living | 2 | 2020 | 570 | 0.630 |
Why?
|
| Leptin | 3 | 2015 | 1590 | 0.630 |
Why?
|
| Insulin Resistance | 6 | 2019 | 3959 | 0.620 |
Why?
|
| Obesity | 7 | 2023 | 12919 | 0.600 |
Why?
|
| Diet | 3 | 2019 | 8010 | 0.530 |
Why?
|
| Brain Ischemia | 3 | 2021 | 3127 | 0.510 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2016 | 225 | 0.480 |
Why?
|
| Weight Loss | 3 | 2023 | 2684 | 0.470 |
Why?
|
| Myoclonic Epilepsy, Juvenile | 1 | 2014 | 13 | 0.470 |
Why?
|
| Migraine Disorders | 3 | 2015 | 1693 | 0.460 |
Why?
|
| Cognition Disorders | 2 | 2019 | 3976 | 0.430 |
Why?
|
| Dementia | 4 | 2023 | 2650 | 0.400 |
Why?
|
| Risk Reduction Behavior | 1 | 2018 | 1109 | 0.390 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2023 | 3332 | 0.340 |
Why?
|
| Carotid Artery Diseases | 1 | 2016 | 881 | 0.340 |
Why?
|
| Body Weight | 1 | 2018 | 4611 | 0.300 |
Why?
|
| Atherosclerosis | 4 | 2020 | 3518 | 0.270 |
Why?
|
| Residence Characteristics | 1 | 2015 | 2061 | 0.260 |
Why?
|
| Rural Population | 1 | 2016 | 2268 | 0.250 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2010 | 3985 | 0.240 |
Why?
|
| Body Mass Index | 3 | 2019 | 12914 | 0.240 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 4434 | 0.230 |
Why?
|
| Health Education | 2 | 2009 | 1049 | 0.220 |
Why?
|
| Voice | 1 | 2006 | 267 | 0.210 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2010 | 1348 | 0.210 |
Why?
|
| Secondary Prevention | 2 | 2019 | 1548 | 0.190 |
Why?
|
| Risk Factors | 12 | 2020 | 74333 | 0.190 |
Why?
|
| Hypoglycemic Agents | 3 | 2019 | 3149 | 0.190 |
Why?
|
| Seizures | 1 | 2014 | 2917 | 0.190 |
Why?
|
| Mississippi | 1 | 2019 | 93 | 0.170 |
Why?
|
| Overweight | 2 | 2023 | 2421 | 0.170 |
Why?
|
| Diet, Reducing | 1 | 2023 | 487 | 0.170 |
Why?
|
| Aged | 18 | 2024 | 169143 | 0.170 |
Why?
|
| Teaching Rounds | 1 | 2024 | 275 | 0.170 |
Why?
|
| Maryland | 1 | 2019 | 275 | 0.170 |
Why?
|
| Minnesota | 1 | 2019 | 340 | 0.160 |
Why?
|
| Women's Health | 1 | 2009 | 2056 | 0.160 |
Why?
|
| Risk | 4 | 2017 | 9632 | 0.160 |
Why?
|
| Male | 24 | 2024 | 359718 | 0.160 |
Why?
|
| North Carolina | 1 | 2019 | 325 | 0.160 |
Why?
|
| Middle Aged | 18 | 2021 | 220359 | 0.160 |
Why?
|
| Female | 25 | 2021 | 391246 | 0.160 |
Why?
|
| Perception | 3 | 2010 | 1195 | 0.160 |
Why?
|
| Humans | 33 | 2024 | 760613 | 0.150 |
Why?
|
| Accidental Falls | 1 | 2006 | 1056 | 0.150 |
Why?
|
| American Heart Association | 2 | 2023 | 1081 | 0.150 |
Why?
|
| Diet Records | 1 | 2019 | 427 | 0.150 |
Why?
|
| Health Behavior | 1 | 2009 | 2622 | 0.140 |
Why?
|
| Health Promotion | 1 | 2009 | 2207 | 0.140 |
Why?
|
| Feeding Behavior | 2 | 2019 | 3185 | 0.140 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 939 | 0.140 |
Why?
|
| Anticholesteremic Agents | 1 | 2023 | 987 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 3164 | 0.130 |
Why?
|
| Diet Surveys | 1 | 2019 | 1161 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2017 | 14494 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2018 | 1578 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 36286 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 2017 | 465 | 0.120 |
Why?
|
| Logistic Models | 3 | 2017 | 13312 | 0.120 |
Why?
|
| Recurrence | 4 | 2019 | 8483 | 0.110 |
Why?
|
| Apolipoprotein E4 | 1 | 2018 | 709 | 0.110 |
Why?
|
| Prospective Studies | 7 | 2023 | 54306 | 0.110 |
Why?
|
| Glycemic Index | 1 | 2016 | 396 | 0.110 |
Why?
|
| Piracetam | 1 | 2014 | 88 | 0.110 |
Why?
|
| Goals | 1 | 2019 | 708 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2019 | 550 | 0.110 |
Why?
|
| Odds Ratio | 2 | 2016 | 9716 | 0.110 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 11890 | 0.110 |
Why?
|
| Leukoaraiosis | 1 | 2014 | 116 | 0.110 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 437 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 1392 | 0.100 |
Why?
|
| Head | 1 | 2018 | 922 | 0.100 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 1190 | 0.100 |
Why?
|
| Perceptual Disorders | 1 | 2014 | 197 | 0.100 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 58980 | 0.100 |
Why?
|
| Microvessels | 1 | 2015 | 572 | 0.090 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 892 | 0.090 |
Why?
|
| Smoking | 2 | 2018 | 9073 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2019 | 1607 | 0.090 |
Why?
|
| Ecuador | 1 | 2010 | 61 | 0.090 |
Why?
|
| Mortality | 1 | 2021 | 2916 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2017 | 2659 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2021 | 64981 | 0.080 |
Why?
|
| Cerebral Infarction | 1 | 2014 | 982 | 0.080 |
Why?
|
| Prevalence | 2 | 2017 | 15686 | 0.080 |
Why?
|
| Video Recording | 1 | 2014 | 955 | 0.080 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2020 | 1518 | 0.080 |
Why?
|
| Weight Gain | 1 | 2019 | 2347 | 0.080 |
Why?
|
| Adiposity | 1 | 2018 | 1858 | 0.080 |
Why?
|
| Energy Intake | 1 | 2016 | 2129 | 0.080 |
Why?
|
| Self Report | 1 | 2020 | 3711 | 0.080 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 2167 | 0.080 |
Why?
|
| Proportional Hazards Models | 2 | 2019 | 12531 | 0.080 |
Why?
|
| Urban Population | 1 | 2016 | 2022 | 0.070 |
Why?
|
| Sex Factors | 2 | 2014 | 10546 | 0.070 |
Why?
|
| Neuropsychological Tests | 2 | 2017 | 7022 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 1 | 2020 | 3841 | 0.070 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 5890 | 0.070 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 4013 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 2660 | 0.060 |
Why?
|
| Lipids | 1 | 2016 | 3336 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2020 | 41337 | 0.060 |
Why?
|
| Hypertension | 2 | 2018 | 8595 | 0.060 |
Why?
|
| Stereotyping | 1 | 2006 | 239 | 0.060 |
Why?
|
| HIV Infections | 1 | 2010 | 17165 | 0.050 |
Why?
|
| Epilepsy | 1 | 2018 | 3267 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 8623 | 0.050 |
Why?
|
| Prenatal Care | 1 | 2010 | 1129 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 6964 | 0.050 |
Why?
|
| Exercise | 1 | 2018 | 5787 | 0.050 |
Why?
|
| United States | 3 | 2018 | 72448 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 39262 | 0.050 |
Why?
|
| Incidence | 2 | 2020 | 21391 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2018 | 24102 | 0.040 |
Why?
|
| Health Surveys | 1 | 2010 | 4063 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 25941 | 0.040 |
Why?
|
| Mothers | 1 | 2010 | 2186 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12968 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2014 | 6189 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2010 | 2125 | 0.040 |
Why?
|
| Life Style | 1 | 2009 | 3898 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2014 | 22052 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 1098 | 0.030 |
Why?
|
| Linear Models | 1 | 2006 | 5877 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 7805 | 0.030 |
Why?
|
| Brain | 2 | 2023 | 26951 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 2020 | 1274 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2023 | 2420 | 0.030 |
Why?
|
| Mass Screening | 1 | 2010 | 5422 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2017 | 12427 | 0.030 |
Why?
|
| Time Factors | 2 | 2017 | 40139 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 2014 | 622 | 0.030 |
Why?
|
| Communication | 1 | 2006 | 3849 | 0.020 |
Why?
|
| Age of Onset | 1 | 2018 | 3302 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 5397 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2009 | 5209 | 0.020 |
Why?
|
| Disease Progression | 2 | 2019 | 13505 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 26179 | 0.020 |
Why?
|
| Pregnancy | 1 | 2010 | 29746 | 0.020 |
Why?
|
| Adult | 2 | 2014 | 220007 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2019 | 2165 | 0.020 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 2365 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2018 | 8556 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 6465 | 0.010 |
Why?
|
| Acute Disease | 1 | 2014 | 7268 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 58748 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 87809 | 0.010 |
Why?
|
| Hospitalization | 1 | 2019 | 10789 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14661 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 12289 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20509 | 0.010 |
Why?
|
| Heart Failure | 1 | 2019 | 11848 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 80345 | 0.010 |
Why?
|